Successful Resolution of Glucose Toxicity With the Use of Fixed-Ratio Combination Injection of Basal Insulin and Short-Acting Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist

Chronic hyperglycemia leads to a decrease in glucose-stimulated insulin secretion and an increase in insulin resistance. Resolving these glucose toxicities is pivotal in type 2 diabetes therapy because the decline in insulin secretion and insulin sensitivity causes further hyperglycemia. Conventiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Hiroshi, Muramae, Naokazu, Mori, Kenta, Otsui, Kazunori, Sakaguchi, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277572/
https://www.ncbi.nlm.nih.gov/pubmed/35844351
http://dx.doi.org/10.7759/cureus.25889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277572/
https://www.ncbi.nlm.nih.gov/pubmed/35844351
http://dx.doi.org/10.7759/cureus.25889

Ejemplares similares